Piramal Enterprises board approves scheme for pharma biz demerger; stock up over 2%

Piramal Enterprises board approves scheme for pharma biz demerger; stock up over 2%

AgenciesUpdated: Thursday, October 07, 2021, 03:29 PM IST
article-image
The pharmaceuticals business will get demerged from Piramal Enterprises (PEL) and consolidated in Piramal Pharma |

The board of Piramal Enterprises has approved a composite scheme of arrangement providing for the demerger of its pharmaceuticals business and simplification of the corporate structure to create two listed entities in financial services and pharmaceuticals.

The pharmaceuticals business will get demerged from Piramal Enterprises (PEL) and consolidated in Piramal Pharma, Piramal Enterprises said in a regulatory filing.

The amalgamation of PHL Fininvest with PEL will create a listed non-banking financial services entity, it added.

The merged housing finance company, post DHFL acquisition, will remain a 100 per cent subsidiary of Piramal Enterprises, the filing said.

Shares of Piramal Enterprises were trading at Rs 2,924.45 per scrip on BSE, up 2.90 per cent from its previous close.

RECENT STORIES

Holy Cities Like Ayodhya, Varanasi Attracting Big Retail Brands: Report

Holy Cities Like Ayodhya, Varanasi Attracting Big Retail Brands: Report

A Big Relief For Byjus's: NCLT Rejects Investor Plea To Stay Byju's Rights Issue EGM On March 29...

A Big Relief For Byjus's: NCLT Rejects Investor Plea To Stay Byju's Rights Issue EGM On March 29...

Your Chocolates To Get Costly As Cocoa Price Surges To ₹8,33,892 Per Ton

Your Chocolates To Get Costly As Cocoa Price Surges To ₹8,33,892 Per Ton

Level Unlocked: Coal India Attains Annual Target, Scales 610.8-MT Supply

Level Unlocked: Coal India Attains Annual Target, Scales 610.8-MT Supply

Fiscal Year 2024 Farewell: Sensex At 73,635.48 & Nifty Above 22,300 As Markets End In Green;...

Fiscal Year 2024 Farewell: Sensex At 73,635.48 & Nifty Above 22,300 As Markets End In Green;...